enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. VIVUS Obesity Drug Sales Only About 60% of Expectations - AOL

    www.aol.com/news/2013-02-25-vivus-obesity-drug...

    VIVUS has traded in a 52-week trading range of $9.86 to $31.21, and the consensus analyst price target from Thomson Reuters was $19.59 before the effects of today's earnings.

  3. VVUS: New Ideas for Established Portfolio

    www.aol.com/news/vvus-ideas-established...

    We are initiating coverage of VIVUS, Inc. (VVUS) with a $10.00 price target based on our revenue forecasts for approved products. In addition to a portfolio of weight loss, exocrine pancreatic ...

  4. Why VIVUS Lost in November - AOL

    www.aol.com/news/2012-12-04-why-vivus-lost-in...

    VIVUS' (NAS: VVUS) stock was down 25% for November, though still up 15% for the year. Its drug Qsymia is the first obesity drug to be approved and reach the market in more than a decade, but its ...

  5. Does The VIVUS, Inc. (NASDAQ:VVUS) Share Price Fall ... - AOL

    www.aol.com/news/does-vivus-inc-nasdaq-vvus...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Buy, Sell, or Hold: VIVUS

    www.aol.com/2012/06/12/buy-sell-or-hold-vivus

    For premium support please call: 800-290-4726 more ways to reach us

  7. Is a VIVUS Buyout Still on the Table? And if So, by Whom? - AOL

    www.aol.com/news/2012-10-12-is-a-vivus-buyout...

    For premium support please call: 800-290-4726 more ways to reach us

  8. Choi Jin-hee (entrepreneur) - Wikipedia

    en.wikipedia.org/wiki/Choi_Jin-hee_(entrepreneur)

    With a closing price of ₩82,100 on September 8, it appeared that a 200% valuation return was achieved. Studio Dragon had granted Choi 72,800 shares as stock options for being the first CEO of Studio Dragon in 2016. The first time Choi exercised stock options was in August 2019, when she exercised options for 21,840 shares.

  9. Hefty Profits in Store for Obesity-Drug Makers - AOL

    www.aol.com/news/2012-02-29-hefty-profits-in...

    For premium support please call: 800-290-4726 more ways to reach us